| For: | Zheng L, Duan SL, Dai YC, Wu SC. Role of adherent invasive Escherichia coli in pathogenesis of inflammatory bowel disease. World J Clin Cases 2022; 10(32): 11671-11689 [PMID: 36405271 DOI: 10.12998/wjcc.v10.i32.11671] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i32/11671.htm |
| Number | Citing Articles |
| 1 |
Tao Zhang, Zhetan Ren, Feng Feng, Ru Man, Longfei Shao, Hongkun Zhang, Xiaozhen Cheng, Lei Gong, Jirun Peng, Yongduo Yu. Gut microbiota-mucosal immunity crosstalk in the IBD microenvironment: Mechanistic insights into disease progression and intervention strategies. The Innovation Life 2026; 4(2) doi: 10.59717/j.xinn-life.2026.100179
|
| 2 |
Yu Jeong Kim, Nayoon Park, Xiaoliang Cheng, Yonghyun Lee. Advanced engineering of microbiome-related therapeutics for targeted treatment of inflammatory bowel diseases. Journal of Controlled Release 2026; 394 doi: 10.1016/j.jconrel.2026.114872
|
| 3 |
Yasmin N. Ramadan, Salwa Q. Bukhari, Zinab Alatawi, Ghaleb Oriquat, Noura H. Abd Ellah, Eltayib Hassan Ahmad Mohamedosman, Rehab Ahmed, Helal F. Hetta. Evolutionary Genomics of Human Gut Bacteria: Ecological Plasticity Across the Mutualism–Pathogenicity Spectrum. International Journal of Molecular Sciences 2026; 27(11) doi: 10.3390/ijms27115009
|
| 4 |
Phage Therapy - Part B. Progress in Molecular Biology and Translational Science 2023; 201 doi: 10.1016/bs.pmbts.2023.04.005
|
| 5 |
Rika Tanaka, Jin Imai, Eiji Sugiyama, Shogo Tsubaki, Katsuto Hozumi, Hitoshi Tsugawa. Cyclic-di-AMP confers an invasive phenotype on Escherichia coli through elongation of flagellin filaments. Gut Pathogens 2024; 16(1) doi: 10.1186/s13099-024-00600-4
|
| 6 |
Yage Bu, Lingli Feng, Di Xu, Shuai Zhang, Liang Liang, Jinglei Si, Yujie Lu, Qiaoling Liu, Gang Yan, Yubin Wang, Ganqiu Lan, Jing Liang. Changes in Gut Microbiota Associated with Parity in Large White Sows. Animals 2023; 14(1) doi: 10.3390/ani14010112
|
| 7 |
Catherine E Thamayandhi, Atanu Manna, Abhimanyu K Singh, Divya Lakshmanan. Type 1 fimbrial protein FimH of Enterobacteriaceae—a promising target to mitigate different infections. Journal of Applied Microbiology 2026; 137(2) doi: 10.1093/jambio/lxag016
|
| 8 |
Linlin Zhuang, Jiansen Gong, Mengling Zhu, Ying Zhao, Xue Lian, Chuang Zhou, Xia Cao, Yu Zhang, Qiuping Shen. Advances in gene-targeted diagnostics for pathogenic Escherichia coli. The Analyst 2026; 151(1) doi: 10.1039/D5AN00836K
|
| 9 |
Erica Bonazzi, Fuhua Hao, Andrew D. Patterson, Laurent Peyrin-Biroulet, Benjamin A.H. Jensen, Benoit Chassaing. Microbiota modulation by a human Paneth cell α-defensin fragment protects against DSS-induced colitis. iScience 2026; 29(1) doi: 10.1016/j.isci.2025.114310
|
| 10 |
Gaetano Iaquinto, Giuseppe Mazzarella, Carmine Sellitto, Angela Lucariello, Raffaele Melina, Salvatore Iaquinto, Antonio De Luca, Vera Rotondi Aufiero. Antibiotic Therapy for Active Crohn’s Disease Targeting Pathogens: An Overview and Update. Antibiotics 2024; 13(2) doi: 10.3390/antibiotics13020151
|
| 11 |
Rosa Paola Radice, Valeria Iannelli, Francesca Padula, Vincenzo De Fabrizio, Marios Drosos, Antonio Scopa, Giuseppe Martelli. The Potential Role of Microalgal Antioxidant Molecules on the Microbiota–Gut Axis in Inflammatory Bowel Diseases. Biomolecules 2025; 15(11) doi: 10.3390/biom15111535
|
| 12 |
Harshal Sawant, Rajesh Selvaraj, Prasath Manogaran, Alip Borthakur. Intestinal Epithelial Creatine Transporter SLC6A8 Dysregulation in Inflammation and in Response to Adherent Invasive E. coli Infection. International Journal of Molecular Sciences 2024; 25(12) doi: 10.3390/ijms25126537
|
| 13 |
Yusaku Tsugami, Taketoshi Iwata, Aoi Sugiyama, Megumi Onishi, Kei-ichi Nakajima, Makoto Osaki, Yuya Nagasawa. Involvement of adhesins (EcpD, FdeC, FimH) expressed in mammary pathogenic Escherichia coli on adhesion to bovine mammary epithelial cells. Antonie van Leeuwenhoek 2025; 118(1) doi: 10.1007/s10482-024-02025-0
|
| 14 |
Nafisa Tabassum, Haruyuki Nakayama-Imaohji, Emmanuel Munyeshyaka, Ayano Tada, Takeo Kondo, Sonoko Kondo, Takashi Kusaka, Tomomi Kuwahara. Reactivity of Autologous Serum IgG to Gut Microbes in Pediatric Ulcerative Colitis. International Journal of Molecular Sciences 2025; 26(17) doi: 10.3390/ijms26178196
|
| 15 |
Mohammed Bourhia, Md. Eram Hosen, Md Omar Faruqe, Faria Tasnim, Mohamed Taibi, Amine Elbouzidi, Yousef A. Bin Jardan, Samir Ibenmoussa, Abdeslam Asehraou. Unveiling Therapeutic Avenues for Crohn’s Disease Management:
Exploring Inhibitors for Adherent-Invasive Escherichia coli Propanediol
Dehydratase. Medicinal Chemistry 2024; 20(7) doi: 10.2174/0115734064295521240227052730
|
| 16 |
Sumanpreet Kaur, Raman Thakur. Gut microbiota and inflammatory bowel disease: mechanisms, clinical implications, and future directions. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-025-11195-7
|
| 17 |
Ling Wang, Xiangfeng He, Zhen Zhang, Nan Chen. Distinct gut microbiota signatures in older people with sarcopenic obesity and sarcopenia without obesity. Clinical Nutrition 2025; 49 doi: 10.1016/j.clnu.2025.04.004
|
| 18 |
Qi-Ming Zhou, Lie Zheng. Research progress on the relationship between Paneth cells-susceptibility genes, intestinal microecology and inflammatory bowel disease. World Journal of Clinical Cases 2023; 11(34): 8111-8125 doi: 10.12998/wjcc.v11.i34.8111
Abstract(841) |
Core Tip(838) |
Full Article(HTML)(3127)
|
Full Article (PDF)-1676K(258)
|
Full Article with Cover (PDF)-1891K(216)
|
Full Article (Word)-752K(37)
|
Full Article (XML)-317K(162)
|
Audio-1485K(12)
|
Peer-Review Report-261K(140)
|
Answering Reviewers-270K(132)
|
Times Cited (1)
|
Total Visits (4365)
|
Open
|
| 19 |
Chinasa Valerie Olovo, Dickson Kofi Wiredu Ocansey, Ying Ji, Xinxiang Huang, Min Xu. Bacterial membrane vesicles in the pathogenesis and treatment of inflammatory bowel disease. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2341670
|
| 20 |
Anindo Dango, Sumaia Jannat, Deepto Chandra Modak, S M Riaduzzaman Niaz, Md. Shah Poran Shuvo, Abdullah Al Mamun, Fee Faysal Ahmed, Md. Khairul Islam. Silver nanoparticles from Solanum tuberosum peel extract combat drug-resistant E. coli – A multidisciplinary approach. The Microbe 2025; 9 doi: 10.1016/j.microb.2025.100563
|
| 21 |
Eve WL Chow, Li M Pang, Yue Wang. The impact of the host microbiota on Candida albicans infection. Current Opinion in Microbiology 2024; 80 doi: 10.1016/j.mib.2024.102507
|
| 22 |
Aycan Gundogdu, Muzaffer Arikan, Alican Ulas, Seda Sevilay Koldaş, Gulfem Ece. From dysbiosis to therapy: Shared gut microbial signatures and targeted interventions across liver, heart and brain disorders. Next Research 2025; 2(4) doi: 10.1016/j.nexres.2025.100846
|
| 23 |
Maria Sofia Molonia, Federica Lina Salamone, Francesco Cimino, Manuela D'Arrigo, Mariateresa Cristani, Luana Pulvirenti, Antonella Saija, Antonio Speciale, Edoardo Napoli. Phenolic Profile and In Vitro Anti‐Inflammatory Activities of Salvia officinalis L. Hydrodistillation Wastewater. Chemistry & Biodiversity 2026; 23(1) doi: 10.1002/cbdv.202502271
|
| 24 |
Arumugam Vignesh, Thomas Cheeran Amal, Raya Soltane, Lienda Bashier Eltayeb, Krishna Kumar Yadav. A Review on Functional Foods Regulate the Gut Microbiota and Mast Cell Function in Inflammatory Bowel Disease (IBD). Probiotics and Antimicrobial Proteins 2026; 18(3) doi: 10.1007/s12602-025-10751-8
|
| 25 |
Lingyun Xu, Yingchao Li, Yingli He. The variation characteristics of fecal microbiota in remission UC patients with anxiety and depression. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1237256
|
| 26 |
Xudong Tang, Yilin Huang, Ying Zhu, Yin Xu. Immune dysregulation in ulcerative colitis: pathogenic mechanisms and therapeutic strategies of traditional Chinese medicine. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1610435
|
| 27 |
Jasmine Teoh Wen Yi, Norfilza Mohd Mokhtar, Raja Affendi Raja Ali, Siti Khadijah Kiraman, Mohamad Syahmi Iskandar Sahran, Hajar Fauzan Ahmad. Draft whole genome sequence of Paenibacillus sp., a novel facultative anaerobic bacteria isolated from an inflammatory bowel disease patient. The Microbe 2025; 9 doi: 10.1016/j.microb.2025.100600
|
| 28 |
Jaika M. I. Rutgrink, Anje A. te Velde. From Diet to Inflammasome: Ultra-Processed Foods as Upstream Drivers of NLRP3-Mediated Intestinal Inflammation in Inflammatory Bowel Disease. Immuno 2026; 6(2) doi: 10.3390/immuno6020024
|
| 29 |
Kai Wang, Sheng-Lei Duan, Lie Zheng. Research progress concerning the involvement of the intestinal microbiota in the occurrence and development of inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(42): 113170 doi: 10.3748/wjg.v31.i42.113170
|
| 30 |
Miryam Adelfio, Grace E. Callen, Xuesong He, Bruce J. Paster, Hatice Hasturk, Chiara E. Ghezzi. Engineered Tissue Models to Decode Host–Microbiota Interactions. Advanced Science 2025; 12(23) doi: 10.1002/advs.202417687
|
| 31 |
Katerina Maeder, Mytien Nguyen, Jiong Yu. Gut Microbiome Variability in Pediatric Patients With Inflammatory Bowel Disease. Advanced Gut & Microbiome Research 2025; 2025(1) doi: 10.1155/agm3/9002193
|
| 32 |
G. Leccese, M. Chiara, I. Dusetti, D. Noviello, E. Billard, A. Bibi, G. Conte, C. Consolandi, M. Vecchi, MP Conte, N. Barnich, F. Caprioli, F. Facciotti, M. Paroni.
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn’s disease is suppressed by
rfaP
and
ybaT
deletion
. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2380064
|
| 33 |
Héloïse Rytter, Hannah Sturgeon, Benoit Chassaing. Diet–pathobiont interplay in health and inflammatory bowel disease. Trends in Microbiology 2025; 33(9) doi: 10.1016/j.tim.2025.04.003
|